The Food and Drug Administration has announced plans to print possible psychiatric side effects on the labels of drugs including Concerta and Ritalin.
The FDA said it would also investigate other drugs used to treat attention deficit hyperactivity disorder, or ADHD, for similar problems, The Wall Street Journal reported Wednesday.
The organization said on its Web site that it has received reports of patients experiencing hallucinations, suicidal thoughts, psychotic behavior, aggression and violent actions while using forms of methylphenidate -- the generic name for Novartis AG's Ritalin. Concerta, made by Johnson & Johnson, is a long-acting form of methylphenidate.
Link... http://www.nlm.nih.gov/medlineplus/news/fullstory_25512.html
The FDA said it would also investigate other drugs used to treat attention deficit hyperactivity disorder, or ADHD, for similar problems, The Wall Street Journal reported Wednesday.
The organization said on its Web site that it has received reports of patients experiencing hallucinations, suicidal thoughts, psychotic behavior, aggression and violent actions while using forms of methylphenidate -- the generic name for Novartis AG's Ritalin. Concerta, made by Johnson & Johnson, is a long-acting form of methylphenidate.
Link... http://www.nlm.nih.gov/medlineplus/news/fullstory_25512.html